Effects of Jump Rope on Navicular Drop in Down Syndrome

February 23, 2026 updated by: Riphah International University

Effects of Jupming Rope on Navicular Drop and Foot Posture in Children With Down Syndrome

foot posture in children with Down syndrome. The current study will be randomized control trial, data will be collected from Tanzeem ul Lissan School FSD, Children Hospital FSD and Allied Hospital FSD. The study will include 32 patients equally divided into two groups and randomly allocated. Inclusion criteria for the study will be Children between the age of 4 to 15 years with navicular drop and prone foot. Patients with visual or auditory impairment, lower limb trauma, recent Surgical Intervention on lower limb will be excluded from the study. Experimental group will perform jumping rope combined with play activities and control group will be given play activities. Data collection will be done before and after the intervention. Tools used for data collection will be Navicular Drop Test and Foot Posture Index .Data will be analyzed through SPSS version 23.00.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Navicular drop is a condition where the navicular bone descends, often leading to flatfoot and poor foot posture. This is particularly significant in children with Down syndrome, who are prone to foot structure abnormalities that can affect their mobility and overall physical activity. Children with Down syndrome frequently experience altered foot mechanics, which can contribute to navicular drop and associated complications. These biomechanical changes is crucial for developing targeted interventions that can enhance foot health and improve quality of life. The aim of this study is to investigate the effects of jumping rope and play activities on reducing navicular drop and improving foot posture in children with Down syndrome.

The current study will be randomized control trial, data will be collected from Tanzeem ul Lissan School FSD, Children Hospital FSD and Allied Hospital FSD. The study will include 32 patients equally divided into two groups and randomly allocated. Inclusion criteria for the study will be Children between the age of 4 to 15 years with navicular drop and prone foot. Patients with visual or auditory impairment, lower limb trauma, recent Surgical Intervention on lower limb will be excluded from the study. Experimental group will perform jumping rope combined with play activities and control group will be given play activities. Data collection will be done before and after the intervention. Tools used for data collection will be Navicular Drop Test and Foot Posture Index .Data will be analyzed through SPSS version 23.00.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
32

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Recruiting
        • Model Town Football Club [Recruiting]
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age of 4 to 15 years
  • navicular drop
  • prone foot
  • Acute musculoskeletal injuries
  • Normal: 5-10 mm
  • Excessive Drop: >10 mm (indicating possible flatfoot)
  • Minimal Drop: <5 mm (indicating a higher arch)

Exclusion Criteria:

  • visual or auditory impairment
  • lower limb trauma
  • recent Surgical Intervention on lower limb
  • Non- compliance and behavioral issue
  • Inability to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Group A:
Group A will perform jumping rope combined with play activities. The program will focus on strengthening and improving the functionality of foot and ankle muscles, promoting better balance and posture. The program will include jumping rope and play activities (one-leg hopping game, walking games on toes, reverse rope walk, straight rope walk, bottle rolling walk, pick and drop game) and these games will be performed to improve the arch, muscle strength, and endurance of foot muscles. The intensity of the jumping rope and play activities will gradually be increased depending on the patient's improvement in activity performance by decreasing the amount or degree of passive support, changing the patient's position, and adjusting the sets and repetitions of activities. Duration period to perform the activities is for 30 mint per session 5 days a week for six weeks.
Other: jumping rope and play activities
jumping rope will focus on strengthening and improving the functionality of foot and ankle muscles, promoting better balance and posture. jumping rope and play activities (one-leg hopping game,walking games on toes, reverse rope walk, straight rope walk, bottle rolling walk,pick and drop game) and these games will be performed to improve the arch, muscle strength, and endurance of foot muscles. The intensity of the jumping rope and play activities will gradually be increased depending on the patient's improvement in activity performance by decreasing the amount or degree of passive support, changing the patient's position, and adjusting the sets and repetitions of activities.
Active Comparator: group B
Group B will perform Play Activities .Play Activites are all dynamic activities commonly used to improve balance, coordination, and foot function, especially in children. These exercises engage various muscles of the lower limbs, improving proprioception, stability, and strength. For children with foot postural deviations like navicular drop, these activities can help reduce excessive pronation and strengthen the foot's arch. Duration period to perform the excercises is for 30 mint per session 5 days a week for six weeks.Data will be assessed by assessor at baseline and at the end o of treatment (Pre and post).
Other: play activities
Group B will perform Play Activities .Play Activites are all dynamic activities commonly used to improve balance, coordination, and foot function, especially in children. These exercises engage various muscles of the lower limbs, improving proprioception, stability, and strength. For children with foot postural deviations like navicular drop, these activities can help reduce excessive pronation and strengthen the foot's arch. Duration period to perform the excercises is for 30 mint per session 5 days a week for six weeks.Data will be assessed by assessor at baseline and at the end o of treatment (Pre and post).

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
foot posture index-6
Time Frame: 30 minutes per session 5 days a week for six weeks.
The patient should be instructed to stand still, with their arms by the side and looking straight ahead.
30 minutes per session 5 days a week for six weeks.
navicular drop test
Time Frame: 30 minutes per session 5 days a week for six weeks.
Navicular Drop Test (NDT) using a ruler or digital caliper.Measures the difference in navicular height between sitting (non-weight-bearing) and standing (weight-bearing) positions.
30 minutes per session 5 days a week for six weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Adil Munir, MS-PT, Study Principal Investigator Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 28, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 20, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 23, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 17, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 23, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 24, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 24, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 23, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCR&AHS/MEHAKTAHREEM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Down Syndrome

Clinical Trials on jumping rope and play activities

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings